SS
CLOV icon

STG Securities’s Clover Health Investments CLOV Stock Holding History

STG Securities’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.5K Buy
+12,683
New +$43.1K ﹤0.01% 496

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

STG Securities's CLOV Position: Q2 2026 in Review

STG Securities opened a new position in Clover Health Investments (CLOV) in Q2 2026: 12,683 shares worth $66.5K. The stake represents ﹤0.01% of the portfolio and ranks #496 among its holdings.

223 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • STG Securities held 12,683 shares of Clover Health Investments worth $66.5K as of Q2 2026.
  • Clover Health Investments was a new STG Securities position in Q2 2026.
  • Clover Health Investments made up ﹤0.01% of STG Securities's portfolio in Q2 2026, its #496 holding.
  • 223 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on STG Securities's 13F filing for Q2 2026, filed 13 Aug 2026.